A Washington, D.C.-based children’s hospital has sued the federal government for authorizing drugmaker Johnson & Johnson (J&J) to perform “unlawful” [...] …
Category: Pharma Industry
Four diabetes drugmakers are urging a federal appeals court to uphold a lower court’s decision to dismiss 340B antitrust claims [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two drugmakers recently announced that they will refund 340B covered entities that purchased certain medications following adjustments to their ceiling [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A law firm representing hospitals and other 340B covered entities across the U.S. has called on more than two dozen [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal government is likely to continue opposing 340B rebate models even as it moves to resolve four separate contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Beginning Oct. 1, AstraZeneca will tighten its 340B contract pharmacy restrictions to require claims data on 340B utilization at contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Exclusive
Arkansas Plans to Challenge J&J’s Contested 340B Rebate Proposal for Violation of State Law
Arkansas plans to challenge Johnson & Johnson’s (J&J’s) 340B rebate proposal for violating the state’s law barring drugmaker contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Maryland federal district judge has denied four separate drug industry attempts to block the state’s contract pharmacy access law—marking [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. government is asking a federal district court in Washington, D.C., to rule for drugmakers in four separate lawsuits [...] …